| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M401350200 |
| P698 | PubMed publication ID | 14996829 |
| P2093 | author name string | Alan L Schneyer | |
| Herbert Y Lin | |||
| Alnoor Pirani | |||
| Jodie L Babitt | |||
| Elisabetta del Re | |||
| P2860 | cites work | Crystal structure of the BMP-2-BRIA ectodomain complex | Q22254423 |
| Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor | Q24290737 | ||
| Differential Binding and Neutralization of Activins A and B by Follistatin and Follistatin Like-3 (FSTL-3/FSRP/FLRG) | Q24299900 | ||
| The soluble exoplasmic domain of the type II transforming growth factor (TGF)-beta receptor. A heterogeneously glycosylated protein with high affinity and selectivity for TGF-beta ligands | Q24313061 | ||
| Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death | Q24563654 | ||
| The crystal structure of TGF-beta 3 and comparison to TGF-beta 2: implications for receptor binding | Q24674065 | ||
| ??? | Q28202242 | ||
| The 1.1 A crystal structure of human TGF-beta type II receptor ligand binding domain | Q27639364 | ||
| The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly | Q27640861 | ||
| Mechanisms of TGF-beta signaling from cell membrane to the nucleus | Q27860785 | ||
| Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease | Q28202655 | ||
| Smad-dependent and Smad-independent pathways in TGF-beta family signalling | Q28208250 | ||
| Mechanism of activation of the TGF-beta receptor | Q28245861 | ||
| Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily | Q28284251 | ||
| Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction | Q28284617 | ||
| An unusual feature revealed by the crystal structure at 2.2 A resolution of human transforming growth factor-beta 2 | Q28291529 | ||
| Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system | Q28304498 | ||
| Expression cloning and characterization of the TGF-beta type III receptor | Q28304515 | ||
| Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos | Q28508310 | ||
| The transforming growth factor-beta family | Q29615948 | ||
| Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene | Q29616540 | ||
| A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity | Q33886942 | ||
| The types II and III transforming growth factor-beta receptors form homo-oligomers | Q36234419 | ||
| Oligomeric structure of type I and type II transforming growth factor beta receptors: homodimers form in the ER and persist at the plasma membrane | Q36276659 | ||
| A soluble transforming growth factor-beta (TGF-beta ) type I receptor mimics TGF-beta responses | Q38297197 | ||
| Chimeric extracellular domain type II transforming growth factor (TGF)-beta receptor fused to the Fc region of human immunoglobulin as a TGF-beta antagonist | Q38334929 | ||
| Betaglycan presents ligand to the TGF beta signaling receptor. | Q41542611 | ||
| Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase | Q41639273 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 22765-22772 | |
| P577 | publication date | 2004-03-02 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2. | |
| P478 | volume | 279 |
| Q37705779 | Abnormal expression of TGF-beta type II receptor isoforms contributes to acute myeloid leukemia |
| Q33298457 | Alternative splicing of TGF-betas and their high-affinity receptors T beta RI, T beta RII and T beta RIII (betaglycan) reveal new variants in human prostatic cells |
| Q83600817 | Bmi1 drives hepatocarcinogenesis by repressing the TGFβ2/SMAD signalling axis |
| Q24316099 | Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression |
| Q24292739 | DRAGON, a bone morphogenetic protein co-receptor |
| Q35840270 | Development and characterization of human monoclonal antibodies that neutralize multiple TGFβ isoforms. |
| Q83299268 | Fibrogenesis in alcoholic chronic pancreatitis: the role of tissue necrosis, macrophages, myofibroblasts and cytokines |
| Q28575076 | Identification of endoglin in rat hepatic stellate cells: new insights into transforming growth factor beta receptor signaling |
| Q50933544 | Multiple Soluble TGF-β Receptors in Addition to Soluble Endoglin Are Elevated in Preeclamptic Serum and They Synergistically Inhibit TGF-β Signaling |
| Q27023170 | Oligomeric interactions of TGF-β and BMP receptors |
| Q40505841 | Reconstitution and analysis of soluble inhibin and activin receptor complexes in a cell-free system |
| Q28510682 | Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor |
| Q24304414 | Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4 |
| Q33872593 | Roles for the type III TGF-beta receptor in human cancer |
| Q39214677 | Syndecan-2 is a key regulator of transforming growth factor beta 2/Smad2-mediated adhesion in fibrosarcoma cells. |
| Q37359962 | TGF-beta signaling in vascular biology and dysfunction |
| Q36541256 | TGFβRIIb mutations trigger aortic aneurysm pathogenesis by altering transforming growth factor β2 signal transduction |
| Q58111148 | The Controversial Role of TGF-β in Neovascular Age-Related Macular Degeneration Pathogenesis |
| Q42578955 | The type III TGF-β receptor betaglycan transmembrane-cytoplasmic domain fragment is stable after ectodomain cleavage and is a substrate of the intramembrane protease γ-secretase |
| Q46238849 | Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk. |
| Q46200196 | Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone |
| Q40199821 | Transforming growth factor-beta3 increases the invasiveness of endometrial carcinoma cells through phosphatidylinositol 3-kinase-dependent up-regulation of X-linked inhibitor of apoptosis and protein kinase c-dependent induction of matrix metallopro |
Search more.